导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.39% | 647/1050 |
| 近一周 | -3.04% | 925/1104 |
| 近一月 | -2.58% | 461/1103 |
| 近一季 | 0.86% | 262/1092 |
| 近半年 | -8.49% | 727/1070 |
| 近一年 | 7.01% | 432/1018 |
| 近两年 | 61.87% | 422/926 |
| 近三年 | 41.25% | 326/834 |
| 成立以来 | 519.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.89% 345/1070 |
-9.87% 903/1101 |
- - |
- - |
| 2025 | 35.59% 385/1065 |
5.31% 395/1014 |
-2.08% 850/1038 |
22.08% 534/1050 |
7.71% 76/1065 |
| 2024 | 10.31% 281/1011 |
1.13% 256/960 |
-0.25% 322/983 |
14.26% 277/991 |
-4.29% 614/1011 |
| 2023 | -2.91% 156/952 |
5.47% 296/880 |
-2.66% 348/895 |
-3.15% 212/915 |
-2.35% 259/952 |
| 2022 | -28.28% 582/867 |
-15.88% 305/773 |
5.81% 471/806 |
-13.12% 470/845 |
-7.25% 712/867 |
| 2021 | -1.52% 372/740 |
-2.60% 247/580 |
2.66% 503/659 |
-4.53% 332/704 |
3.17% 298/740 |
| 2020 | 42.64% 284/554 |
-7.86% 352/419 |
14.94% 355/466 |
16.55% 117/517 |
15.57% 193/554 |
| 2019 | 42.94% 198/410 |
31.83% 275/1149 |
-4.10% 654/1231 |
3.39% 236/390 |
9.36% 181/410 |
| 2018 | -20.61% 91/349 |
- - |
- - |
- - |
-7.81% 140/1080 |
| 2017 | 28.07% 49/285 |
- - |
- - |
- - |
- - |
| 2016 | 6.46% 13/205 |
- - |
- - |
- - |
- - |
| 2015 | 35.18% 44/151 |
- - |
- - |
- - |
- - |
| 2014 | 60.25% 1/24 |
- - |
- - |
- - |
- - |
| 2013 | 10.36% 14/21 |
- - |
- - |
- - |
- - |
| 2012 | 4.98% 86/157 |
- - |
- - |
- - |
- - |
| 2011 | -19.39% 31/102 |
- - |
- - |
- - |
- - |
| 2010 | 8.17% 6/58 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 汇丰晋信大盘股票A VS. 东吴新产业精选股票A(580008) |